• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与Castleman病相关的AA型淀粉样变性:一例病例报告及文献复习

AA amyloidosis associated with Castleman disease: A case report and review of the literature.

作者信息

Bernabei Luca, Waxman Adam, Caponetti Gabriel, Fajgenbaum David C, Weiss Brendan M

机构信息

Penn Amyloidosis Program, Abramson Cancer Center.

Department of Pathology and Laboratory Medicine.

出版信息

Medicine (Baltimore). 2020 Feb;99(6):e18978. doi: 10.1097/MD.0000000000018978.

DOI:10.1097/MD.0000000000018978
PMID:32028407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7015640/
Abstract

RATIONALE

AA amyloidosis (AA) is caused by a wide variety of inflammatory states, but is infrequently associated with Castleman disease (CD). CD describes a heterogeneous group of hematologic disorders that share characteristic lymph node histopathology. CD can present with a solitary enlarged lymph node (unicentric CD, UCD) or with multicentric lymphadenopathy (MCD), constitutional symptoms, cytopenias, and multiple organ dysfunction due to an interleukin-6 driven cytokine storm.

PATIENT CONCERNS

We are reporting a case of a 26-year-old woman with no significant past medical history who presented with a 3-month history of fatigue and an unintentional 20-pound weight loss.

DIAGNOSIS

A CT-scan of the abdomen and pelvis revealed hepatosplenomegaly and a mesenteric mass. Congo Red staining from a liver biopsy showed apple-green birefringence and serum markers were suggestive of an inflammatory process. Post-excision examination of the resected mass revealed a reactive lymph node with follicular hyperplasia with kappa and lambda stains showing polyclonal plasmacytosis consistent with CD.

INTERVENTIONS

The patient underwent surgery to remove the affected lymph node.

OUTCOMES

IL-6, anemia, leukocytosis, and thrombocytosis resolved or normalized 2 weeks after resection; creatinine normalized 9 months postsurgery. Twenty two months post-surgery her IFN-γ normalized, her fatigue resolved, her proteinuria was reduced by >90% and she had returned to her baseline weight.

LESSONS

Our case and literature review suggest that patients presenting with UCD or MCD along with organ failure should prompt consideration of concurrent AA amyloidosis.

摘要

理论依据

AA型淀粉样变性(AA)由多种炎症状态引起,但很少与Castleman病(CD)相关。CD描述了一组具有特征性淋巴结组织病理学的异质性血液系统疾病。CD可表现为单个肿大淋巴结(单中心CD,UCD)或多中心淋巴结病(MCD)、全身症状、血细胞减少以及由于白细胞介素-6驱动的细胞因子风暴导致的多器官功能障碍。

患者情况

我们报告一例26岁女性患者,既往无重大病史,出现3个月的疲劳史及非故意体重减轻20磅。

诊断

腹部和盆腔CT扫描显示肝脾肿大及肠系膜肿块。肝活检刚果红染色显示苹果绿双折射,血清标志物提示炎症过程。切除肿块的术后检查显示为反应性淋巴结伴滤泡增生,κ和λ染色显示多克隆浆细胞增多,符合CD。

干预措施

患者接受手术切除受累淋巴结。

结果

切除术后2周,白细胞介素-6、贫血、白细胞增多和血小板增多症得到缓解或恢复正常;术后9个月肌酐恢复正常。术后22个月,她的干扰素-γ恢复正常,疲劳症状消失,蛋白尿减少>90%,体重恢复到基线水平。

经验教训

我们的病例及文献回顾表明,出现UCD或MCD并伴有器官衰竭的患者应考虑同时存在AA型淀粉样变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/67e7efc9c20b/medi-99-e18978-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/4c81e7195a43/medi-99-e18978-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/46e50a7b8f97/medi-99-e18978-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/67e7efc9c20b/medi-99-e18978-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/4c81e7195a43/medi-99-e18978-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/46e50a7b8f97/medi-99-e18978-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a863/7015640/67e7efc9c20b/medi-99-e18978-g003.jpg

相似文献

1
AA amyloidosis associated with Castleman disease: A case report and review of the literature.与Castleman病相关的AA型淀粉样变性:一例病例报告及文献复习
Medicine (Baltimore). 2020 Feb;99(6):e18978. doi: 10.1097/MD.0000000000018978.
2
Rapid Clinical Improvement of Multicentric Castleman Disease (MCD) with Renal Involvement Following Treatment with Tocilizumab: AA Amyloidosis as a Possible Renal Involvement of MCD.托珠单抗治疗后合并肾脏受累的多中心Castleman病(MCD)临床快速改善:AA淀粉样变性作为MCD可能的肾脏受累情况
Tohoku J Exp Med. 2023 Mar 15;259(4):285-291. doi: 10.1620/tjem.2023.J003. Epub 2023 Jan 19.
3
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.托珠单抗在组织学上改善了一名多中心Castleman病患者的AA型肾淀粉样变性:病例报告
Clin Nephrol. 2018 Sep;90(3):232-236. doi: 10.5414/CN109273.
4
Epidemiology of Castleman disease associated with AA amyloidosis: description of 2 new cases and literature review.Castleman 病相关淀粉样变性的流行病学:2 例新病例描述及文献复习。
Amyloid. 2019 Dec;26(4):197-202. doi: 10.1080/13506129.2019.1641078. Epub 2019 Jul 31.
5
Systemic reactive amyloidosis associated with Castleman's disease: serial changes of the concentrations of acute phase serum amyloid A and interleukin 6 in serum.与Castleman病相关的系统性反应性淀粉样变性:血清中急性期血清淀粉样蛋白A和白细胞介素6浓度的系列变化
J Clin Pathol. 1997 Nov;50(11):965-7. doi: 10.1136/jcp.50.11.965.
6
Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease.AA 淀粉样变心肌病合并单中心 Castleman 病的恢复。
BMJ Case Rep. 2022 Aug 18;15(8):e250338. doi: 10.1136/bcr-2022-250338.
7
A CARE-compliant article: Unicentric Castleman disease presenting as a retroperitoneal mass of the upper edge of the pancreas: A case report.一篇符合CARE标准的文章:表现为胰腺上缘腹膜后肿块的单中心Castleman病:病例报告。
Medicine (Baltimore). 2020 Mar;99(11):e19515. doi: 10.1097/MD.0000000000019515.
8
Amyloidosis secondary to intrapulmonary Castleman disease mimicking pulmonary hyalinizing granuloma-like clinical features: A rare case report.继发于肺内Castleman病的淀粉样变性,酷似肺透明变性肉芽肿样临床特征:1例罕见病例报告
Medicine (Baltimore). 2019 Apr;98(14):e15039. doi: 10.1097/MD.0000000000015039.
9
Virome capture sequencing does not identify active viral infection in unicentric and idiopathic multicentric Castleman disease.病毒组捕获测序不能在局灶性和特发性多中心 Castleman 病中识别出活跃的病毒感染。
PLoS One. 2019 Jun 26;14(6):e0218660. doi: 10.1371/journal.pone.0218660. eCollection 2019.
10
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report.同步性单中心 Castleman 病和炎症性肝细胞腺瘤:一例报告。
Ann Hepatol. 2019 Jan-Feb;18(1):263-268. doi: 10.5604/01.3001.0012.7936.

引用本文的文献

1
The morphological spectrum of Castleman disease and related disorders: a report from the Lymphoma Workshop of the 22nd Meeting of the European Association of Hematopathology.Castleman病及相关疾病的形态学谱:欧洲血液病理学协会第22次会议淋巴瘤研讨会报告
Virchows Arch. 2025 Jul 12. doi: 10.1007/s00428-025-04171-w.
2
Unicentric Castleman's disease presenting as amyloid A cardiac amyloidosis: a case report.表现为淀粉样蛋白A心脏淀粉样变性的单中心Castleman病:一例报告
Ann Hematol. 2024 Jan;103(1):367-368. doi: 10.1007/s00277-023-05493-y. Epub 2023 Oct 26.
3
Axillary Lymphadenopathy as an Initial Presentation of Systemic Amyloidosis: A Case Report and Literature Review.

本文引用的文献

1
Tocilizumab histologically improved AA renal amyloidosis in a patient with multicentric Castleman disease: A case report
.托珠单抗在组织学上改善了一名多中心Castleman病患者的AA型肾淀粉样变性:病例报告
Clin Nephrol. 2018 Sep;90(3):232-236. doi: 10.5414/CN109273.
2
Plasma proteomics identifies a 'chemokine storm' in idiopathic multicentric Castleman disease.血浆蛋白质组学鉴定出特发性多中心 Castleman 病中的“趋化因子风暴”。
Am J Hematol. 2018 Jul;93(7):902-912. doi: 10.1002/ajh.25123. Epub 2018 May 16.
3
Castleman Disease Pathogenesis.卡斯特尔曼病的发病机制
腋窝淋巴结病作为全身性淀粉样变性的初始表现:一例病例报告及文献复习。
J Investig Med High Impact Case Rep. 2022 Jan-Dec;10:23247096221133191. doi: 10.1177/23247096221133191.
4
Recovery from AA amyloidosis-cardiomyopathy complexed with unicentric Castleman disease.AA 淀粉样变心肌病合并单中心 Castleman 病的恢复。
BMJ Case Rep. 2022 Aug 18;15(8):e250338. doi: 10.1136/bcr-2022-250338.
Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21. doi: 10.1016/j.hoc.2017.09.002.
4
Clinical characteristics and outcomes of Castleman disease: A multicenter study of 185 Chinese patients.Castleman病的临床特征与预后:185例中国患者的多中心研究
Cancer Sci. 2018 Jan;109(1):199-206. doi: 10.1111/cas.13439. Epub 2017 Dec 28.
5
Unicentric Castleman's disease associated with end stage renal disease caused by amyloidosis.与淀粉样变性所致终末期肾病相关的单中心Castleman病。
World J Clin Cases. 2017 Mar 16;5(3):119-123. doi: 10.12998/wjcc.v5.i3.119.
6
Relapse of HHV8-positive multicentric Castleman disease following rituximab-based therapy in HIV-positive patients.利妥昔单抗治疗 HIV 阳性患者后,HHV8 阳性多中心 Castleman 病复发。
Blood. 2017 Apr 13;129(15):2143-2147. doi: 10.1182/blood-2016-10-747477. Epub 2017 Jan 31.
7
Tocilizumab for AA Amyloidosis after Treatment of Multicentric Castleman Disease with Steroids, Chemotherapy and Rituximab for Over 20 Years.托珠单抗用于多中心Castleman病经类固醇、化疗和利妥昔单抗治疗20多年后的AA型淀粉样变性。
Intern Med. 2015;54(24):3215-9. doi: 10.2169/internalmedicine.54.4183. Epub 2015 Dec 15.
8
Report of six kidney disease-associated Castleman's disease cases.6例与肾脏疾病相关的Castleman病病例报告。
Clin Nephrol. 2015 Dec;84(6):344-52. doi: 10.5414/CN108621.
9
[Clinical and morphological features of different types of Castleman's disease].[不同类型Castleman病的临床及形态学特征]
Ter Arkh. 2015;87(7):64-71. doi: 10.17116/terarkh201587764-71.
10
Colchicine therapy in amyloidosis related with plasmacytic Castleman disease presenting with nephrotic syndrome.秋水仙碱治疗与表现为肾病综合征的浆细胞性Castleman病相关的淀粉样变性。
Saudi J Kidney Dis Transpl. 2015 Sep;26(5):992-5. doi: 10.4103/1319-2442.164589.